Intrauterine Adhesion Clinical Trial
Official title:
Safety and Efficacy of Intrauterine Biological Barrier on Postoperative Adhesion After Hysteroscopic Adhesiolysis: a Prospective, Multicentre, Randomized, Positive Parallel Controlled, Non-inferiority, Clinical Trail
To evaluate the safety and efficacy of Intrauterine Biological Barrier developed and produced by Chengdu TopRegMed Medical Technology Co., Ltd on postoperative adhesion after Hysteroscopic Adhesiolysis.
This study is a prospective, multicenter, randomized, parallel positive-control, non-inferior clinical trial, with the purpose to evaluate the efficacy and safety of Intrauterine Biological Barrier for the prevention or reduction of intrauterine adhesions after Hysteroscopic Adhesiolysis. The trial will be conducted at six clinical centers with 264 subjects who meet all the inclusion/ exclusion criteria. Subjects will be randomly assigned to the experimental group and the control group in a 1:1 ratio. Subjects in the test group were treated with Intrauterine Biological Barrier (IBB) made by Chengdu TopRegMed Medical Technology Co. , Ltd. , while the patients in the positive control group were treated with commercially approved Intrauterine Adhesion Barrier Gel for uterine cavity made by Changzhou Bioregen biopharmaceutical Co. , Ltd. . Subjects will be followed up for 12 months (360 days ± 30 days) after implantation. 73-days (± 12 days) after operation, the safety and effectiveness of IBB will be evaluated by demonstrating non-inferiority to commercially approved gel. If test group is non-inferiority, further study will be performed to explore whether the safety and effectiveness of the IBB is better than the control group in the aspect of the recurrence rate of intrauterine adhesion, types of intrauterine adhesion, postoperative endometrial repair, menstrual recovery and 1-year pregnancy rate. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04972032 -
Efficacy of Estrogen-intrauterine Stent System After Intrauterine Adhesiolysis
|
N/A | |
Recruiting |
NCT03381807 -
Human Amniotic Epithelial Stem Cell in Treatment of Refractory Severe Intrauterine Adhesion
|
Early Phase 1 | |
Recruiting |
NCT03329898 -
Comparing the Efficacy of Two Methods for the Therapy of Uterine Adhesion
|
N/A | |
Completed |
NCT03724617 -
Clinical Study of Umbilical Cord Mesenchymal Stem Cells Combined With Collagen Scaffold in the Treatment of Thin Endometrium
|
N/A | |
Recruiting |
NCT03330873 -
The Efficacy and Safety of Disposable Balloon Uterine Stent in Patients With Asherman Syndrome
|
N/A | |
Completed |
NCT02220621 -
Efficacy and Safety of Crosslinked Hyaluronan Gel for Preventing Intrauterine Adhesion
|
N/A | |
Active, not recruiting |
NCT04963179 -
PREvention of Intrauterine Adhesion After Adhesiolysis With Novel Tri-block deGradable Polymer Film.
|
N/A | |
Recruiting |
NCT03351205 -
The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Completed |
NCT04381728 -
PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film
|
N/A | |
Recruiting |
NCT03346317 -
Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Completed |
NCT05414760 -
Evaluate Formation of IUAs After Third-generation Endometrial Ablation, With and Without Intrauterine Adhesion Barrier
|
N/A | |
Completed |
NCT04166500 -
Early Outpatient Hysteroscopy Can Prevent Intrauterine Adhesion After Induced Abortion
|
N/A | |
Recruiting |
NCT03169478 -
Intrauterine Balloon Dilatation Therapy in the Prevention of Adhesion Formation After Hysteroscopic Myomectomy
|
N/A | |
Recruiting |
NCT03171454 -
Immediate and Delayed Intrauterine Balloon in the Prevention of Adhesion Reformation After Hysteroscopic Adhesiolysis
|
N/A | |
Recruiting |
NCT05003869 -
Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions
|
N/A | |
Completed |
NCT02744716 -
Effects of Aspirin on Uterine Endometrial Repair Severe Intrauterine Adhesion
|
N/A | |
Completed |
NCT03131596 -
Postoperative Intermittent Intrauterine Balloon Dilatation Therapy.
|
N/A | |
Completed |
NCT04824430 -
Assessment of Uterine Access, Uterine Patency and Intrauterine Adhesions Following Endometrial Ablation
|
||
Completed |
NCT01167296 -
Safety of Leaving Cook Balloon Uterine Stent in Uterus for One Month
|
Phase 4 | |
Completed |
NCT03578172 -
HMG Stimulation Versus HRT for Endometrial Preparation Prior to Blastocyst Transfer in Moderate to Severe IUA Patients
|
N/A |